Influence of transition metal ions on NMR proton T1 relaxation times of serum, blood, and red cells

Biological Trace Element Research

Volumn 67, Issue 2, 1999, Pages 187-193

  Yilmaz, A ^a   Yurdakoc M ^a   Isik B ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Ions and paramagnetic contribution; NMR; T1

Indexed keywords

CHROMIUM; COBALT; COPPER ION; FERRIC ION; MANGANESE; METAL ION; NICKEL;

ARTICLE; BLOOD; ERYTHROCYTE; HUMAN; HUMAN CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; SERUM;

EID: 0032922895     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02784073     Document Type: Article

References (16)

1. S. Kang, J. C. Gore, and I. M. Armitage, Studies of factors affecting the design of NMR contrast agents: Manganese in blood as a model system, Magn. Resonance Med. 1, 396-409 (1984).
2. J. I. Barnhart and R. N. Berk, Influence of paramagnetic ions and pH on proton NMR relaxation of biological fluids, Invest. Radiol. 21, 132-136 (1986).
3. D. D. Stark, M. E. Moseley, B. R. Bacon, A. A. Moss, H. I. Goldberg, N. M. Bass, et al., Magnetic resonance imaging and spectroscopy of hepatic iron overload, Radiology 154, 137-134 (1985).
4. V. M. Runge, J. A. Clanton, F. W. Smith, J. Hutchison, J. Mallard, C. L. Partain, et al., Nuclear Magnetic Resonance of iron and copper disease states, AJR 141, 943-948 (1983).
5. P. D. Jensen, F. T. Jensen, T. Christensen, and J. Ellegaard, Non-invasive assessment of tissue iron overload in the liver by Magn. Resonance Imaging, Br. J. Haematol. 87, 171-84 (1994).
6. P. D. Jensen, F. T. Jensen, T. Christensen, and J. Ellegaard, Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients, Br. J. HaematoI. 89, 880-889 (1985).
7. J. Grellet, M. F. Bellin, and E. Dion, Contrast media in hepatic MRI, J. Radiol. 73, 495-499 (1992).
8. K. Yoshikawa, Y. Sasaki, N. Ogawa, and S. Sakuma, Clinical application of AMI-25 (super paramagnetic iron oxide) for the MR imaging of hepatic tumors, Nippon-Igaku Hoshasen-Gakkai-Zasshi 54, 137-153 (1994).
9. S. H. Koenig, C. M. Baglin, and R. D. Brown III, Magnetic field dependence of solvent proton relaxation in aqueous solutions of Fe(III) complexes, Magn. Resonance Med. 2, 283-288 (1985).
10. +++, J. Chem. Phys. 31, 365-368 (1959).
11. S. H. Koenig and R. D. Brown III, Relaxation of solvent protons by paramagnetic ions and its dependence on magnetic field and chemical environment: Implications for NMR imaging, Magn. Resonance Med. 1, 478-495 (1984).
12. A. Yitmaz, L. Ciraolo, R. Renzi, G. Longo, F. Franciolini, and A. Bianchi, Spin-lattice relaxation rates in Fe(III)-doped human serum measured by MRI, Clin. Phys. Physiol. Meas. 10, 361-364 (1989).
13. A. Yilmaz, M. Tez, V. Göral, Ş. Boylu, A. Kaplan, and G. Kayak, In vitro NMR proton T1 measurements in peritoneal ascites, Phys. Med. Biol. 41, 539-549 (1996).
14. A. Yilmaz, B. Otludil, M. S. Batun, Y. Ensari, R. Longo, and L. D. Palma, Determination of iron and iron binding capacity by NMR, Phys. Med. Biol. 37, 1589-1596 (1992).
15. J. L. Thomas, Nuclear Magnetic Resonance in Biochemistry, 1st ed., Academic, New York (1975).
16. B. G. Jenkins, E. Armstrong, and R. B. Lauffer, Site-specific water proton relaxation enhancement of iron(III) chelates noncovalently bound to human serum albumin, Magn. Resonance Med. 17, 164-178 (1991).